Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer
- Conditions
- Pancreas DiseasePancreatic Cyst
- Interventions
- Diagnostic Test: Bio-Specimen Collection
- Registration Number
- NCT03260842
- Lead Sponsor
- Stanford University
- Brief Summary
Bio-repository to collect bio-specimens from patients with 1) pancreatic cysts and 2) patients at high risk, defined by family history and/or genetic mutations, for pancreatic cancer.
- Detailed Description
Observational study to collect bio-specimens from 2 separate patient cohorts identified to be at high risk for subsequent development of pancreas cancer.
1. Patients diagnosed with a pancreatic cyst undergoing either endoscopic ultrasound or surgery. Bio-specimens collected include pancreatic cyst fluid and blood. These will be collected using a standard operating protocol.
2. Patients defined as a high risk individual for pancreas cancer by family history and/or known genetic mutations. Bio-specimens collected include blood. This will be collected using a standard operating protocol.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 500
- Older than 18 with pancreas cyst
- Older than 18 at high risk for Pancreas cancer
- Unable to provide consent
- Not willing to provide bio-specimens
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description High Risk Individuals Bio-Specimen Collection Patients with established family history and/or genetic mutations for Pancreas cancer who will have bio-specimens collected Pancreatic Cysts Bio-Specimen Collection Patients with pancreatic cyst undergoing endoscopic ultrasound and/or surgery who will have bio-specimens collected
- Primary Outcome Measures
Name Time Method Pancreas Cancer 5-10 years Development of Pancreas Cancer
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Stanford University
🇺🇸Stanford, California, United States